{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:17:02Z","timestamp":1771654622062,"version":"3.50.1"},"reference-count":20,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1179\/joc.2007.19.5.596","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:06:04Z","timestamp":1389290764000},"page":"596-598","source":"Crossref","is-referenced-by-count":1,"title":["Mutant Prevention Concentrations of Tetracycline, Rifampicin and Ciprofloxacin for<i>Brucellae melitensis<\/i>"],"prefix":"10.1080","volume":"19","author":[{"given":"A.Y.","family":"Coban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tanyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tasdelen Fisgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Darka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tulek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Durupinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02243.x"},{"key":"CIT0002","first-page":"2669","volume-title":"Mandell, Douglas and Bennett's Principles and Practice of Infectious Disease. Fifth ed.","author":"Young EJ","year":"2005"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(99)00049-7"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/AAC.43.1.194","volume":"43","author":"Trujillano-Martin I","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2006.08.018"},{"key":"CIT0006","unstructured":"Winn, Jr W, Allen S, Janda W, Koneman E et al. Koneman's Color Atlas and Textbook of Diagnostic Microbiology, Sixth edition. Chapter 9, Miscellaneous Fastidious Gram-Negative Bacilli, Lippincott Co, Philadelphia, 2006; p 488-490."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2581-2584.2000"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg269"},{"key":"CIT0009","first-page":"3337","volume":"44","author":"Sindelar G","year":"2000","journal-title":"Mutant prevention concentration as a measure of flouro-quinolone potency against mycobacteria. Antimicrob Agnets Chemother"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.03.011"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Blondeau JM, Zhao X, Hansen G, Drlica K. Mutant prevention concentration of fluoroquinolones for clinical iso-lates of Streptococcus pneumoniae. Antimicrob Agents Chemother 200145: 433-438.","DOI":"10.1128\/AAC.45.2.433-438.2001"},{"key":"CIT0012","first-page":"49: 1633","volume":"2005","author":"Hermsen ED","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl135"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2005.11.007"},{"key":"CIT0016","first-page":"564","volume":"134","author":"Roushan MRH","year":"2004","journal-title":"Swiss Med Wkly"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-1-25"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.3.441"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1159\/000238662"},{"key":"CIT0020","first-page":"2061","volume":"39","author":"Solera J","year":"1995","journal-title":"Doxycycline-rifampicin versus doxycy-cline-streptomycine in treatment of human brucellosis due to Brucellae melitensis. Antimicrob Agents Chemother"},{"key":"CIT0021","unstructured":"Lorian M. Antibiotics in laboratory medicine. Fifth Ed, Lippincott Williams&Wilkins, USA, 2005: p773, 786, 790."}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T04:50:37Z","timestamp":1565067037000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2007.19.5.596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1179\/joc.2007.19.5.596"],"URL":"https:\/\/doi.org\/10.1179\/joc.2007.19.5.596","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}